MYCAPSSA

OCTREOTIDE · Chiesi USA, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for MYCAPSSA, covering 2020-06-26 to 2025-03-21. Get the full timeline:

Most recent: EMA Withdrawn: Mycapssa (octreotide acetate) — Amryt Pharmaceuticals DAC